Effects of sex- and glucocorticoid steroids on breast cancer cells grown as either multicellular tumor spheroids or monolayers

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 1, 1996, Pages 13-19

  Müller Holzner, Elisabeth ^a   Marth, Christian ^a   Zeimet, Alain G ^a   Hofstädter, Ferdinand ^b   Daxenbichler, Günter ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANDROSTANOLONE; DEXAMETHASONE; ESTRADIOL; GLUCOCORTICOID; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; SEX HORMONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOLAYER CULTURE; TUMOR SPHEROID;

EID: 0030130448     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)81485-3     Document Type: Article

References (48)

1. 1. Davidson N. E. and Lippman M. E.: The role of estrogens in growth regulation of breast cancer. Oncogenesis 1 (1989) 89-104.
2. 2. Brünner N., Bronzert D., Vindelov L. L., Rygaard K., Spang-Thomsen M. and Lippman M. E.: Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer Res. 49 (1989) 1515-1520.
3. 3. Furman E., Rushkin E., Margalit R., Bendel P. and Degani H.: Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging. J. Steroid Biochem. Molec. Biol. 43 (1992) 189-195.
4. 4. Marth C. and Daxenbichler G.: Pulsatile versus continuous estradiol exposure in inducing proliferation of cultured ZR-75-1 human breast cancer cells. J. Steroid Biochem. 23 (1985) 567-572.
5. 5. Osborne C. K., Hobbs K. and Clark G. M.: Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 45 (1985) 584-590.
6. 6. Marth C., Daxenbichler G., Buehring G. C., Hofstädter F. and Dapunt O.: Inhibition of the estradiol-induced growth of cultured human breast cancer cells by the anti-estrogens tamoxifen, desmethyl-tamoxifen, 4-hydroxy-tamoxifen and enclomiphene. Biochem. Pharmac. 33 (1984) 3951-3956.
7. co human breast cancer cells by progestins: implication for endocrine therapies. Cancer Res. 45 (1985) 167-173.
8. 8. Sutherland R. C., Hall R. E., Pang G. Y., Musgrove E. A. and Clarke C. L.: Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer Res. 48 (1988) 5084-5091.
9. 9. Braunsberg H., Goldham N. G., Leake R. E., Cowan S. K. and Wong W.: Action of a progestogen on human breast cancer cells: Mechanism of growth stimulation and inhibition. Eur. J. Cancer Clin. Oncol. 23 (1987) 563-571.
10. 10. Ruedl C., Cappeletti V., Coradini D., Granata G. and Di Franzo G.: Influence of culture conditions on the estrogenic cell growth stimulation of human breast cancer cells. J. Steroid Biochem. Molec. Biol. 37 (1990) 195-200.
11. 11. Klosterboer H. J., Schoonen W. G. E. J., Deckers G. H. and Klijn J. G. M.: Effects of progestagens and Org OD14 in in vitro and in vivo tumor models. J. Steroid Biochem. Molec. Biol. 49 (1994) 311-318.
12. 12. Jung M. H., Parker C. J. and Jordan V. C.: Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Cancer Res. 52 (1992) 6539-6546.
13. 13. Van der Burg B., Kalkhoven E., Isbrücker L. and De Laat S. W.: Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor derived conditions. J. Steroid. Biochem. Molec. Biol. 42 (1992) 457-465.
14. 14. Markiewicz L. and Gurpide E.: Estrogenic and progestagenic activities coexisting in steroidal drugs: Quantitative evaluation by in vitro bioassays with human cells. J. Steroid Biochem. Molec. Biol. 48 (1994) 89-94.
15. 15. Catherino W. H., Jung M. H. and Jordan V. C.: Norgestrel and gestodene stimulate breast cancer growth through an estrogen receptor mediated mechanism. Br. J. Cancer 67 (1993) 945-952.
16. 16. Reed M. J., Ross M. S., Lai L. C., Ghilchik M. W. and James V. H. T.: In vivo conversion of norethisterone to ethinyloestradiol in perimenopausal women. J. Steroid Biochem. Molec. Biol. 37 (1990) 301-303.
17. 17. Luthy I. A., Begin D. J. and Labire F.: Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shinogi) cells in culture. J. Steroid Biochem. Molec. Biol. 31 (1988) 845-852.
18. 18. Poulin R., Baker D., Poirier D. and Labrie F.: Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res. and Treat. 13 (1989) 161-172.
19. 19. Carlsson J. and Nederman T.: Tumor spheroid technology in cancer therapy research. Eur. J. Cancer Clin. Oncol. 25 (1989) 1127-1133.
20. 20. Sutherland R. M.: Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240 (1988) 177-184.
21. 21. Conger A. D. and Ziskin M. C.: Growth of mammalian multicellular tumor spheroid. Cancer Res. 43 (1983) 556-560.
22. 22. Demicheli R., Foroni R., Ingrosso A., Pratesi G., Soranzo C. and Tortoreto M. : An exponential-Gompertzian description of LoVo tumor growth from in vivo and in vitro data. Cancer Res. 49 (1989) 6543-6546.
23. 23. Norton L. A.: Gompertzian model of human breast cancer growth. Cancer Res. 48 (1988) 7067-7071.
24. 24. Sutherland R. M., Sordart B., Barnat I., Gabbert H., Bourrat B. and Mueller-Klieser W.: Oxygenation and differentiation of multicellular spheroids of human colon carcinoma. Cancer Res. 46 (1986) 5320-5329.
25. 25. Olea N., Villalobos M., Ruiz de Almodovar J. M. and Pedraza V: MCF-7 breast cancer cells grown as multicellular spheroids in vitro: effect of 17 beta-estradiol. Int. J. Cancer 50 (1992) 112-117.
26. 26. Yuhas J. M., Tarleton A. E. and Molzen K. B.: Multicellular tumor spheroid formation by breast cancer cells isolated from different sites. Cancer Res. 38 (1978) 2486-2491.
27. 27. Engel L. W., Young N. A., Tralka T. S., Lippman M. E., O'Brien S. J. and Joyce M. J.: Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res. 38 (1978) 3352-3364.
28. 28. Lasfargues E. Y., Cantinho W. G. and Moore I. H.: Heterotransplantation of a human breast carcinoma cell line. Cancer Res. 32 (1972) 2365-2368.
29. 29. Horwitz K. B., Zava D. T., Thilagar A. K., Jensen E. M. and McGuire W. L.: Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res. 38 (1978) 2434-2437.
30. 30. Yuhas J. M., Li A. P., Martinez A. O. and Ladman A. J.: A simplified method for production and growth of multicellular tumor spheroids (MTS). Cancer Res. 37 (1977) 3639-3643.
31. 31. Berthois Y, Katzenellenbogen J. A. and Katzenellenbogen B. S.: Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc. Natn. Acad. Sci. U.S.A. 83 (1986) 2496-2500.
32. 32. Poulin R., Simard J., Labrie C., Petitclerc L., Dumong M., Lagace L. and Labrie F.: Down-regulation of estrogen receptors by androgens in the ZR-75-1 breast cancer cell line. Endocrinology 125 (1989) 392-399.
33. 33. Cormier E. M. and Jordan V. C.: Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factor. Eur. J. Cancer Clin. Oncol. 25 (1989) 57-63.
34. 34. Vignon F., Bouton M. M. and Rochefort H.: Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem. Biophys. Res. Comm. 146 (1987) 1502-1508.
35. 35. Sutherland R. L., Watts C. K. W., Hall R. E. and Ruenitz P. C.: Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells. J. Steroid. Biochem. 27 (1987) 891-897.
36. 36. Charlier C., Chariot A., Antoine N., Merville M. P., Gielen J. and Castronovo V.: Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MD-435 Cells. Biochemical Pharmacology 49 (1995) 351-358.
37. 37. Hoelting T., Siperstein A. E., Duh Qu. Y. and Clark O. H.: Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo. J. Clin. Endocrinol Metabol. 80 (1995) 308-313.
38. 38. Horwitz K. B.: The structure and function of progesterone receptors in breast cancer. J. Steroid Biochem. 27 (1987) 447-457.
39. 39. Castiglione Gertsch M., Pampallona S., Varini M., Cavalli F., Brunner K., Senn H. J., Goldhirsch A. and Metzger U.: Primary endocrine therapy for advanced breast cancer: to start with tamoxifen or with medroxyprogesterone acetate? Ann. Oncol. 4 (1993) 735-740.
40. 40. Parazzini F., Colli E., Scatigna M. and Tozzi L.: Treatment with tamoxifen and progestins for metastatic breast cancer in postmenopausal women: a quantitative review of published randomized clinical trials. Oncology 50 (1993) 483-489.
41. 41. Knüchel R., Feichtinger J., Recktenwald A., Hollweg H. G., Franke P., Jakse G., Rammal E. and Hofstädter F.: Interactions between bladder tumor cells as tumor spheroids from the cell line J82 and human endothelial cells in vitro. J. Urol. 139 (1988) 640-645.
42. 42. Knüchel R., Hofstädter F., Jenkins W. E. A. and Masters J. R. W.: Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy. Cancer Res. 49 (1989) 1397-1401.
43. 43. Donaldson J. T., Tucker J. A., Keane T. E., Walther P. J. and Webb K. S.: Characterization of a new model of human prostatic cancer: the multicellular tumor spheroid. Int. J. Cancer 46 (1990) 238-244.
44. 44. Durand R. E.: Chemosensitivity testing in V79 spheroids: drug delivery and cellular microenvironment. J. Natl. Cancer Inst. 77 (1986) 247-252.
45. 45. Sutherland R. and Durand R. E.: Radiation response of multicell spheroids - an in vitro tumour model. Current Top. Radiat. Res. Quart. 11 (1976) 87-139.
46. 46. Stuschke M., Budach V. and Sack H.: Radioresponsiveness of human glioma, sarcoma, and breast cancer spheroids depends on tumor differentiation. Int. J. Radiat. Oncol. Biol. Phys. 27 (1993) 627-636.
47. 47. Pourreau-Schneider N., Berthois Y., Mittre H., Charpin C., Jacquemier J. and Martin P. M.: Estrogen response of MCF-7 cells grown on diverse substrates and in suspension culture: promotion of morphological heterogeneity, modulation of progestin receptor induction; cell-substrate interactions on collagen gels. J. Steroid Biochem. 21 (1984) 763-771.
48. 48. Freiss G., Prébois C. and Vignon F.: Control of breast cancer cell growth by steroids and growth factors: Interactions and mechanisms. Breast Cancer Res. Treat. 27 (1993) 57-68.